Gefurulimab and Generalized Myasthenia GravisTRACK

Sound

Gefurulimab and Generalized Myasthenia Gravis

16:42 duration0 plays0 favoritesMedium quality
Play now

About this track

Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy

From the album

JAMA Neurology Author Interviews album coverJAMA Neurology Author Interviews25 tracks · Track 23

Interviews with authors of articles from JAMA Neurology. JAMA Neurology is an international peer-rev...

→

More By JAMA Network...

You may also like